US President Donald Trump has revealed plans to soon name the next Federal Reserve chairman, emphasizing a candidate who "believes in lower interest rates by a lot." This statement signals a potential shift toward more accommodative monetary policy, which could have significant implications for financial markets, including cryptocurrencies.US President Donald Trump has revealed plans to soon name the next Federal Reserve chairman, emphasizing a candidate who "believes in lower interest rates by a lot." This statement signals a potential shift toward more accommodative monetary policy, which could have significant implications for financial markets, including cryptocurrencies.

Trump to Announce Fed Chair Soon: "Someone Who Believes in Lower Interest Rates by a Lot"

2025/12/18 17:43
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
News Brief
US President Donald Trump has revealed plans to soon name the next Federal Reserve chairman, emphasizing a candidate who "believes in lower interest rates by a lot." This statement signals a potential shift toward more accommodative monetary policy, which could have significant implications for financial markets, including cryptocurrencies.

Keywords: Trump Fed chair announcement, lower interest rates Trump, Federal Reserve chairman pick, Trump monetary policy, crypto impact Fed rates

US President Donald Trump has revealed plans to soon name the next Federal Reserve chairman, emphasizing a candidate who "believes in lower interest rates by a lot." This statement signals a potential shift toward more accommodative monetary policy, which could have significant implications for financial markets, including cryptocurrencies.

Trump's Fed Chair Announcement Plans
In recent comments during an interview or public appearance, Trump stated he will announce his pick for Fed chair imminently, prioritizing someone aligned with aggressive rate cuts. The current chair, Jerome Powell, has faced Trump's criticism for not lowering rates sufficiently. Trump's preference for "lower interest rates by a lot" echoes his first-term pushes for easy money to boost economic growth and stock markets.

Potential nominees include figures like Kevin Warsh or Arthur Laffer, known for dovish views. This comes amid economic data showing slowing inflation, giving room for cuts (Federal Reserve Economic Data).

Context and Economic Background
Trump's focus on low rates aims to stimulate borrowing, investment, and consumer spending. With the Fed's benchmark rate at 4.75-5%, further reductions could address recession fears. However, critics warn of inflation risks, as seen in 2021-2022 spikes.

The announcement is timely, with the Fed's next meeting approaching and markets pricing in a 50% chance of a cut (CME FedWatch Tool).

Implications for Crypto and Markets
Lower rates are typically bullish for risk assets like Bitcoin (BTC), reducing the appeal of fixed-income investments and encouraging speculation. Crypto markets reacted positively, with BTC up 2%, as cheaper money could fuel ETF inflows and adoption (CoinMarketCap BTC Data).

Trump's pro-crypto stance, including Bitcoin reserves, amplifies this, potentially creating a favorable environment for digital assets.

Market Reactions and Outlook
Stocks and crypto rallied on the news, reflecting optimism for stimulus. However, uncertainty around the nominee could introduce volatility. If confirmed, a dovish chair might accelerate cuts, boosting growth but risking bubbles.

As Trump prepares the announcement, watch for market shifts. For updates on Trump Fed chair announcement and lower interest rates impact, stay informed—monetary policy shapes crypto trends.

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.086
$3.086$3.086
-1.40%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles published on this page are written by independent contributors and do not necessarily reflect the official views of MEXC. All content is intended for informational and educational purposes only and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC. Cryptocurrency markets are highly volatile — please conduct your own research and consult a licensed financial advisor before making any investment decisions.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09